PAG
WST icon

Private Advisor Group’s West Pharmaceutical WST Stock Holding History

Private Advisor Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$298K Buy
829
+2
+0.2% +$611 ﹤0.01% 2112
2026
Q1 		$207K Sell
827
-486
-37% -$121K ﹤0.01% 2440
2025
Q4 		$361K Sell
1,313
-58
-4% -$15.9K ﹤0.01% 2031
2025
Q3 		$360K Buy
+1,371
New +$333K ﹤0.01% 1964
2025
Q1 		– Sell
-1,301
Closed -$426K – 2425
2024
Q4 		$426K Sell
1,301
-358
-22% -$113K ﹤0.01% 1664
2024
Q3 		$498K Sell
1,659
-172
-9% -$52.7K ﹤0.01% 1613
2024
Q2 		$603K Buy
1,831
+208
+13% +$73.5K ﹤0.01% 1468
2024
Q1 		$642K Sell
1,623
-11
-0.7% -$4.07K ﹤0.01% 1378
2023
Q4 		$575K Buy
1,634
+230
+16% +$81.4K ﹤0.01% 1379
2023
Q3 		$527K Sell
1,404
-75
-5% -$29K ﹤0.01% 1352
2023
Q2 		$553K Sell
1,479
-25
-2% -$8.93K ﹤0.01% 1329
2023
Q1 		$521K Sell
1,504
-353
-19% -$103K 0.01% 1313
2022
Q4 		$295K Sell
1,857
-118
-6% -$28K 0.01% 756
2022
Q3 		$486K Sell
1,975
-1,501
-43% -$457K 0.01% 1250
2022
Q2 		$1.05M Buy
3,476
+31
+0.9% +$10.1K 0.01% 1043
2022
Q1 		$1.42M Sell
3,445
-107
-3% -$41.9K 0.01% 943
2021
Q4 		$1.67M Sell
3,552
-1,932
-35% -$832K 0.01% 895
2021
Q3 		$2.33M Buy
5,484
+3,475
+173% +$1.46M 0.01% 826
2021
Q2 		$721K Buy
2,009
+884
+79% +$292K 0.01% 1220
2021
Q1 		$317K Sell
1,125
-521
-32% -$149K ﹤0.01% 1529
2020
Q4 		$467K Buy
+1,646
New +$462K ﹤0.01% 1248
2020
Q3 		– Sell
-504
Closed -$114K – 3430
2020
Q2 		$114K Buy
+504
New +$99K ﹤0.01% 1636
2020
Q1 		– Sell
-2,867
Closed -$431K – 1650
2019
Q4 		$431K Buy
2,867
+97
+4% +$14.1K 0.01% 1117
2019
Q3 		$393K Buy
+2,770
New +$381K 0.01% 1172
2019
Q2 		– Sell
-3,083
Closed -$340K – 1735
2019
Q1 		$340K Buy
+3,083
New +$321K 0.01% 1136
2018
Q4 		– Sell
-2,598
Closed -$321K – 1593
2018
Q3 		$321K Sell
2,598
-480
-16% -$53.8K 0.01% 1191
2018
Q2 		$304K Buy
+3,078
New +$283K 0.01% 978
2018
Q1 		– Sell
-2,176
Closed -$221K – 1390
2017
Q4 		$221K Buy
2,176
+24
+1% +$2.35K 0.01% 1029
2017
Q3 		$202K Buy
+2,152
New +$195K 0.01% 1344
2017
Q2 		– Sell
-2,899
Closed -$232K – 1475
2017
Q1 		$232K Buy
2,899
+91
+3% +$7.61K 0.01% 1203
2016
Q4 		$241K Buy
+2,808
New +$221K 0.01% 1051

Other funds holding WST

RP
Riverbridge Partners Minneapolis, Minnesota $3.58B AUM 4.02% 1-Year Est. Return
BTCPP
Border to Coast Pensions Partnership Leeds, United Kingdom $6.78B AUM 31.6% 1-Year Est. Return
VF
Vest Financial Mclean, Virginia $9.52B AUM 31.6% 1-Year Est. Return
Sumitomo Mitsui Trust Group
Sumitomo Mitsui Trust Group Minato-Ku, Tokyo, Japan $175B AUM 40.63% 1-Year Est. Return
BHIA
Birch Hill Investment Advisors Boston, Massachusetts $2.47B AUM 20.95% 1-Year Est. Return
AAM
AMI Asset Management Los Angeles, California $1.74B AUM 26.89% 1-Year Est. Return
SIM
Seilern Investment Management London, United Kingdom $794M AUM 6.63% 1-Year Est. Return
LPPI
Local Pensions Partnership Investment London, United Kingdom $4.77B AUM 20.5% 1-Year Est. Return
CCA
Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return
Asset Management One
Asset Management One Tokyo, Japan $39B AUM 37.51% 1-Year Est. Return

Private Advisor Group's WST Position: Q2 2026 in Review

Private Advisor Group increased its West Pharmaceutical (WST) stake by 0.24% in Q2 2026, buying an estimated $611 and bringing the position to 829 shares worth $298K. The position accounts for ﹤0.01% of the portfolio, ranked #2112.

Private Advisor Group first reported a position in WST in Q4 2016 and has held it in 31 quarters since. The position peaked at $2.33M in Q3 2021. 287 funds tracked by Wall St. Rank hold WST as of Q2 2026.

  • Private Advisor Group held 829 shares of West Pharmaceutical worth $298K as of Q2 2026.
  • Private Advisor Group bought 2 West Pharmaceutical shares in Q2 2026, an estimated $611.
  • West Pharmaceutical made up ﹤0.01% of Private Advisor Group's portfolio in Q2 2026, its #2112 holding.
  • Private Advisor Group first reported a position in West Pharmaceutical in Q4 2016 and has held it in 31 quarters since.
  • Private Advisor Group's West Pharmaceutical position peaked at $2.33M in Q3 2021.
  • 287 funds tracked by Wall St. Rank held West Pharmaceutical as of Q2 2026.

Based on Private Advisor Group's 13F filing for Q2 2026, filed 27 Jul 2026.